Recurrent Glioblastoma

Could there be a gleevec for brain cancer?

The drug Gleevec (imatinib mesylate) is well known not only for its effectiveness against chronic myeloid leukemia (CML) and acute lymphoblastic leukemia, but also for the story behinds its development. The ...

Feb 09, 2015
popularity 27 comments 0

Novel cancer vaccine approach for brain tumors

Glioblastoma is the most common aggressive primary brain tumor, and despite advances in standard treatment, the median survival is about 15 months (compared to 4 months without treatment). Researchers at Thomas Jefferson ...

Nov 13, 2014
popularity 0 comments 0

Latest Spotlight News

A high-fat diet may alleviate mitochondrial disease

Mice that have a genetic version of mitochondrial disease can easily be mistaken for much older animals by the time they are nine months old: they have thinning grey hair, osteoporosis, poor hearing, infertility, ...

Walking in nature found to reduce rumination

(Medical Xpress)—A team of researchers working at Stanford University has found that people walking in a "natural" environment tend to engage in less rumination. In their paper published in Proceedings of ...

Protein's impact on colorectal cancer is dappled

Researchers at University of California, San Diego School of Medicine have discovered a cell signaling pathway that appears to exert some control over initiation and progression of colorectal cancer, the ...